BRIEF published on 09/17/2025 at 07:35, 2 months 27 days ago Sensorion announces its 2025 half-year results Funding Gene Therapy SENS-401 SENS-501 2025 Results
PRESS RELEASE published on 09/17/2025 at 07:30, 2 months 27 days ago Inside Information / News release on accounts, results Sensorion reports 2025 half-year results, corporate update, and availability of half-year report. Progress in gene therapy programs for hearing loss disorders discussed Clinical Trials Gene Therapy Sensorion Hearing Loss Disorders 2025 Half-Year Results
BRIEF published on 09/04/2025 at 07:35, 3 months 10 days ago Sensorion to Present at 60th Inner Ear Biology Workshop Biotechnology Gene Therapy Sensorion Hearing Loss Inner Ear Biology Workshop
PRESS RELEASE published on 09/04/2025 at 07:30, 3 months 10 days ago Inside Information / Other news releases Sensorion announces participation in the 60th Annual Inner Ear Biology Workshop presenting gene therapy research for hearing loss disorders Research Gene Therapy Sensorion Hearing Loss Disorders Inner Ear Biology Workshop
BRIEF published on 08/15/2025 at 07:35, 3 months 30 days ago Sensorion Strengthens its Liquidity Contract with Kepler Cheuvreux Liquidity Biotechnology Euronext Kepler Cheuvreux Sensorion
PRESS RELEASE published on 08/15/2025 at 07:30, 3 months 30 days ago Inside Information / Other news releases Sensorion increases resources allocated to liquidity contract with Kepler Cheuvreux by €60,000 to enhance liquidity of shares on Euronext Paris. The move is in accordance with AMF Decision No. 2021-01 Euronext Paris Liquidity Contract Kepler Cheuvreux AMF Decision Sensorion
BRIEF published on 07/31/2025 at 09:22, 4 months 14 days ago Sensorion Announces Participation in Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Therapies September-October 2025
BRIEF published on 07/01/2025 at 07:35, 5 months 13 days ago Sensorion Reports Positive Preliminary Data from Audiogene Phase 1/2 Trial Gene Therapy Sensorion SENS-501 Congenital Deafness Audiogene Trial
PRESS RELEASE published on 07/01/2025 at 07:30, 5 months 13 days ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
BRIEF published on 05/13/2025 at 07:35, 7 months 1 day ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
Published on 12/14/2025 at 23:00, 2 hours 46 minutes ago Fortescue to Acquire Alta Copper for C$1.40 per Share
Published on 12/13/2025 at 02:00, 1 day 23 hours ago Battery X Metals Announces Confidential Submission of Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 12/13/2025 at 00:13, 2 days 1 hour ago Prospect Ridge Announces Non-Brokered Private Placement
Published on 12/12/2025 at 23:05, 2 days 2 hours ago ReelTime's RLTR Stock Surges Past AI Giants Following LG Smart TV Debut of Reel Intelligence
Published on 12/14/2025 at 14:10, 11 hours 35 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 12/13/2025 at 19:57, 1 day 5 hours ago The Payments Group Holding identifies business activity fields and investment opportunities in AI company building and the biotech sector
Published on 12/13/2025 at 17:00, 1 day 8 hours ago Tapping into "Urban Oilfield": Unlocking the Value of Waste Plastic Film
Published on 12/13/2025 at 11:20, 1 day 14 hours ago Official streaming platform for the Games of the Future Abu Dhabi 2025 powered by ADNOC launches ahead of opening competition
Published on 12/13/2025 at 04:15, 1 day 21 hours ago M7 World Championship unveils first Opening Ceremony, tournament draw, and M7 Pass—elevates Indonesia on global stage
Published on 12/12/2025 at 18:00, 2 days 7 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/11/2025 at 08:30, 3 days 17 hours ago Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe
Published on 12/11/2025 at 08:29, 3 days 17 hours ago Schneider Electric hosts a Capital Markets Day for investors and financial analysts
